4-氟-2-硝基苯甲腈 | 80517-21-1

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 烃类硝化物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟-2-硝基苯甲腈
• 中文别名: 4-氟-2-硝基苯腈；2-硝基-4-氟苯腈
• 英文名称: 4-fluoro-2-nitrobenzonitrile
• 英文别名: 2-nitro-4-fluorobenzonitrile
• CAS: 80517-21-1
• 化学式: C₇H₃FN₂O₂
• mdl: MFCD00277447
• 分子量: 166.111
• InChiKey: MNEAKKQYFSYZEU-UHFFFAOYSA-N

物化性质

• 熔点：
  71 °C
• 沸点：
  145-150 °C(Press: 11.25 Torr)
• 密度：
  1.41±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  69.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn,Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38
• 危险品运输编号：
  UN 3276
• 海关编码：
  2926909090
• 危险性防范说明：
  P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Name:	4-Fluoro-2-nitrobenzonitrile 97% Material Safety Data Sheet
Synonym:
CAS:	80517-21-1

Section 1 - Chemical Product MSDS Name:4-Fluoro-2-nitrobenzonitrile 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
80517-21-1	4-Fluoro-2-nitrobenzonitrile	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 80517-21-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: orange
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 69 - 71 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H3FN2O2
Molecular Weight: 166

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide, acrid smoke and fumes, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 80517-21-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Fluoro-2-nitrobenzonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 80517-21-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 80517-21-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 80517-21-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氟-2-硝基苯甲腈 在 硫酸 作用下， 反应 6.0h， 以73%的产率得到4-氟-2-硝基苯甲酰胺
  参考文献：
  名称：

  Protiva, Miroslav; Jilek, Jiri; Rajsner, Miroslav, Collection of Czechoslovak Chemical Communications, 1986, vol. 51, # 3, p. 698 - 722

  摘要：

  DOI：
• 作为产物：
  描述：

  1,4-二氟苯 在 硫酸 、 氨 、 potassium nitrate 、 sodium nitrite 作用下， 以 水 、 二甲基亚砜 、 N,N-二甲基甲酰胺 为溶剂， 生成 4-氟-2-硝基苯甲腈
  参考文献：
  名称：

  一种2-硝基-4-甲氧基苯甲酸的制备方法

  摘要：

  本发明公开了一种2‑硝基‑4‑甲氧基苯甲酸的工业化制备方法。该2‑硝基‑4‑甲氧基苯甲酸的工业化制备方法，以对二氟苯为初始原料，经硝化、氨解、重氮上溴、氰化、甲氧基化以及水解六步反应合成2‑硝基‑4‑甲氧基苯甲酸。本过程得到的2‑硝基‑4‑甲氧基苯甲酸为白色粉末状固体，纯度98.5%，每步原料转化率分别达到100%，整个过程的总收率达到35.8%。

  公开号：

  CN109553534A

文献信息

• 二氢喹唑啉酮类化合物及其制备方法
  申请人：三峡大学

  公开号：CN108558778B

  公开（公告）日：2021-06-18

  本发明涉及二氢喹唑啉酮类化合物及其制备方法，具体结构如III所示。该方法以廉价易得的邻硝基苯甲腈(I)和醛或酮(II)为原料，以醇和水为溶剂，在四羟基二硼、冰醋酸和催化量的氯化亚铜作用下，在一锅反应体系中经硝基还原、氰基水解以及缩合等反应，得到目标产物(III)。该方法首次使用2‑硝基苯甲腈(I)为原料，操作简便，原料易得、收率较高，具有步骤经济性、原子经济性、反应条件温和等绿色合成的优点。
• [EN] 6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS<br/>[FR] DÉRIVÉS DE 6-1H-IMIDAZO-QUINAZOLINE ET QUINOLÉINES, NOUVEAUX INHIBITEURS DE MAO ET LIGANDS DES RÉCEPTEURS D'IMIDAZOLINES
  申请人：ROTTAPHARM SPA

  公开号：WO2009152868A1

  公开（公告）日：2009-12-23

  The present invention is directed to 6-(1H-imidazo-1-yl)-2-aryl and 2-heteroaryl quinazoline and quinolines derivatives, compounds of formula (I), their pharmaceutical acceptable salts and solvates and corresponding pharmaceutical compositions, that acts as Monoamine Oxidase (MAO) inhibitors and Imidazoline Receptor ligands: wherein: X is independently selected from -CH group or a nitrogen atom (-N), W is independently selected from an aryl group, an heteroaryl group, or a benzocondensed heteroaryl group such as 1,3-benzodioxole, benzofuran, 2,3-dihydrobenzofuran, benzothiophene, 2,3-dihydrobenzothiophene, indole, 2,3-dihydroindole, benzimidazole, benzoxazole, benzothiazole, 2H-3,4-dihydrobenzopyran, [l,4]-benzodioxine, 2,3-dihydro-[1,4]-benzodioxine (1,4-benzodioxan). R1 is independently selected from hydrogen (-H), C1-C4alkyl, hydroxymethyl (-CH2OH), aminomethyl (-CH2NH2), alkylaminomethyl [CH2NH(R2)], or di-alkylaminomethyl [CH2N(R2)2], trifiuoromethyl (-CF3). Compounds of formula (I) elicited a pharmacological profile suitable for the clinical treatment of depression and related disorders, Parkinson disease, drug abuse, and morphine tolerance and dependence.

  本发明涉及6-(1H-咪唑-1-基)-2-芳基和2-杂芳基喹唑啉和喹啉衍生物，这些衍生物的化学式为(I)，以及它们的药用盐和溶剂化物以及相应的药物组合物，作为单胺氧化酶（MAO）抑制剂和咪唑啉受体配体：其中：X独立地选自-CH基团或氮原子(-N)，W独立地选自芳基团、杂芳基团或如1,3-苯并二氧杂环戊烷、苯并呋喃、2,3-二氢苯并呋喃、苯并噻吩、2,3-二氢苯并噻吩、吲哚、2,3-二氢吲哚、苯并咪唑、苯并噁唑、苯并噻唑、2H-3,4-二氢苯并吡喃、[1,4]-苯并二氧杂环戊烷、2,3-二氢-[1,4]-苯并二氧杂环戊烷(1,4-苯并二氧杂环戊烷)。R1独立地选自氢(-H)、C1-C4烷基、羟甲基(-CH2OH)、氨基甲基(-CH2NH2)、烷基氨甲基[CH2NH(R2)]或二烷基氨甲基[CH2N(R2)2]、三氟甲基(-CF3)。化学式(I)的化合物展现出适合于临床治疗抑郁症和相关障碍、帕金森病、药物滥用以及吗啡耐受性和依赖性的药理特性。
• Conversions of aryl carboxylic acids into aryl nitriles using multiple types of Cu-mediated decarboxylative cyanation under aerobic conditions
  作者：Zhengjiang Fu、Xihan Cao、Shuiliang Wang、Shengmei Guo、Hu Cai

  DOI：10.1039/d0ob01945c

  日期：——

  develop efficient and practical protocols for Cu-mediated decarboxylative cyanations, under aerobic conditions, of aryl carboxylic acids bearing nitro and methoxyl substituents at the ortho position as well as of heteroaromatic carboxylic acids. These protocols involved economical methods to synthesize value-added aryl nitriles from simple and inexpensive raw materials. Further diversification of the

  在这里，我们使用丙二腈或 AMBN 作为氰化剂，开发了有效且实用的方案，用于在有氧条件下，对在邻位带有硝基和甲氧基取代基的芳基羧酸以及杂芳族羧酸进行 Cu 介导的脱羧氰化反应。这些协议涉及从简单且廉价的原材料合成增值芳基腈的经济方法。对 2-硝基苯腈产品进行了进一步的多样化, 以突出协议的实用性。
• Copper-Catalyzed One-Pot Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones from 2-Nitrobenzonitriles and Carbonyl Compounds Mediated by Diboronic Acid in Methanol–Water
  作者：Qixing Liu、Yuebo Sui、Yin Zhang、Kaili Zhang、Yongsheng Chen、Haifeng Zhou

  DOI：10.1055/s-0037-1610740

  日期：2020.2

  A copper-catalyzed one-pot synthesis of 2,3-dihydroquinazolin-4(1H)-ones with diboronic acid as a reductant in an aqueous medium is described. Various 2,3-dihydroquinazolin-4(1H)-ones were prepared with good functional-group tolerance in good yields under mild conditions from readily available 2-nitrobenzonitriles and various carbonyl compounds.

  描述了铜催化的 2,3-二氢喹唑啉-4(1H)-酮与二硼酸作为还原剂在水性介质中的一锅法合成。各种 2,3-二氢喹唑啉-4(1H)-酮在温和条件下从容易获得的 2-硝基苯甲腈和各种羰基化合物制备，具有良好的官能团耐受性和良好的产率。
• Combination therapy with CHK1 inhibitors
  申请人：Gesner G. Thomas

  公开号：US20050256157A1

  公开（公告）日：2005-11-17

  Compounds of Structure I, and salts, tautomers, stereoisomers, and mixtures thereof may be used in methods of inhibiting checkpoint kinase 1 in subjects, in methods for inducing cell cycle progression, and in methods for increasing apoptosis in cells. Such compounds may be used to prepare pharmaceutical compositions and may be used in conjunction with DNA damaging agents.

  结构I的化合物及其盐类、互变异构体、立体异构体和混合物可用于抑制受试者中的检查点激酶1，用于诱导细胞周期进展的方法，以及用于增加细胞凋亡的方法。这些化合物可用于制备药物组合物，并且可以与DNA损伤剂联合使用。